Grimes & Company, Inc. Biocryst Pharmaceuticals Inc Transaction History

Grimes & Company, Inc.

$3.66 Billion
Q3 2024

A detailed history of Grimes & Company, Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Grimes & Company, Inc. holds 75,275 shares of BCRX stock, worth $563,809. This represents 0.02% of its overall portfolio holdings.

Number of Shares

75,275

Previous 75,275 -0.0%

Holding current value

$563,809

Previous $465,000 23.01%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$4.13 - $6.79 $15,842 - $26,046	3,836 Added 5.37%	75,275 $465,000
Q1 2024 Apr 17, 2024	SELL	$4.89 - $7.65 $4,479 - $7,007	-916 Reduced 1.27%	71,439 $362,000
Q4 2023 Jan 24, 2024	SELL	$4.98 - $6.77 $6,075 - $8,259	-1,220 Reduced 1.66%	72,355 $433,000
Q3 2023 Oct 19, 2023	BUY	$6.71 - $7.92 $6,059 - $7,151	903 Added 1.24%	73,575 $520,000
Q2 2023 Jul 19, 2023	BUY	$6.96 - $8.81 $2,436 - $3,083	350 Added 0.48%	72,672 $511,000
Q1 2023 Apr 20, 2023	BUY	$7.94 - $11.84 $3,295 - $4,913	415 Added 0.58%	72,322 $603,000
Q4 2022 Jan 25, 2023	SELL	$10.5 - $14.2 $420 - $568	-40 Reduced 0.06%	71,907 $0
Q3 2022 Oct 28, 2022	BUY	$10.79 - $14.81 $10,228 - $14,039	948 Added 1.34%	71,947 $907,000
Q2 2022 Jul 22, 2022	BUY	$7.89 - $17.88 $17,657 - $40,015	2,238 Added 3.25%	70,999 $751,000
Q1 2022 May 06, 2022	BUY	$11.56 - $19.76 $38,020 - $64,990	3,289 Added 5.02%	68,761 $1.12 Million
Q4 2021 Feb 01, 2022	BUY	$11.18 - $15.46 $143,115 - $197,903	12,801 Added 24.3%	65,472 $907,000
Q3 2021 Nov 08, 2021	BUY	$14.21 - $17.65 $29,357 - $36,464	2,066 Added 4.08%	52,671 $757,000
Q2 2021 Aug 04, 2021	SELL	$9.5 - $17.24 $10,991 - $19,946	-1,157 Reduced 2.24%	50,605 $800,000
Q1 2021 May 12, 2021	BUY	$7.37 - $13.61 $116,534 - $215,201	15,812 Added 43.98%	51,762 $526,000
Q4 2020 Feb 02, 2021	BUY	$3.37 - $8.61 $70,601 - $180,379	20,950 Added 139.67%	35,950 $268,000
Q3 2020 Nov 12, 2020	BUY	$3.43 - $5.53 $51,450 - $82,950	15,000 New	15,000 $52,000

Others Institutions Holding BCRX

# of Institutions

280

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Account

Grimes & Company, Inc. Biocryst Pharmaceuticals Inc Transaction History